Expression status of cyclase-associated protein 2 as a prognostic marker for human breast cancer

11Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Cyclase-associated protein 2 (CAP2) protein is reported to be upregulated in hepatocellular carcinoma (HCC). However, data regarding its expression pattern and clinical relevance in breast cancer are unknown. The aim of this study was to investigate CAP2 expression and its prognostic significance in breast cancer. CAP2 expression at the mRNA and protein levels was examined by real-time quantitativepolymerase chain reaction and western blotting in 10 paired breast cancer tissues and adjacent normal tissues. The expression level of CAP2 protein in normal breast epithelial cells and breast cancer cell lines was quantified by western blotting. CAP2 protein expression was analyzed in paraffin-embedded breast cancer samples, paired adjacent non-tumor and normal breast tissues by immunohistochemical analysis. Statistical analyses were also performed to evaluate the clinicopathological significance of CAP2 expression. The results showed that the expression of CAP2 mRNA and protein was higher in breast cancer than that noted in the adjacent normal tissues in 10 paired samples. The expression level of CAP2 protein in breast cancer cell lines was higher than that in normal breast epithelial cells. In paraffin-embedded tissue samples, the expression of CAP2 was higher in breast cancer than that found in the adjacent non-cancerous tissues and normal breast tissues. Compared with the adjacent non-cancerous tissues, overexpression of CAP2 was detected in 29.4% (37/126) of the patients. Overexpression of CAP2 was significantly associated with progesterone receptor (PR) expression (p<0.05), and decreased overall survival (OS) (p<0.05). In multivariate analysis, expression of CAP2 was an independent prognostic factor for OS [hazard ratio (HR), 4.821; 95% confidence interval (CI), 2.442-9.518; p<0.001]. CAP2 is upregulated in breast cancer and is associated with the expression of PR and patient survival. CAP2 may serve as a prognostic indicator for patients with breast cancer.

Cite

CITATION STYLE

APA

Xu, L., Peng, S., Huang, Q., Liu, Y., Jiang, H., Li, X., & Wang, J. (2016). Expression status of cyclase-associated protein 2 as a prognostic marker for human breast cancer. Oncology Reports, 36(4), 1981–1988. https://doi.org/10.3892/or.2016.5051

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free